Table 2.
Day | Bev. 1-Control | Bev. 2-Control | Bev. 3-Control | Ran. 1-Control | Ran. 2-Control | Ran. 3-Control |
---|---|---|---|---|---|---|
2 | 429.4 | 490.6 | 351.3 | 475.0 | 410.0 | 464.9 |
5 | 311.4 | 388.5 | 272.8 | 321.0 | 416.0 | 367.6 |
7 | 224.0 | 323.4 | 217.3 | 207.1 | 297.1 | 294.4 |
14 | 77.2 | 113.8 | 71.1 | 43.5 | 71.8 | 59.1 |
21 | 33.6 | |||||
Day | Bev. 1-PPV | Bev. 2-PPV | Bev. 3-PPV | Ran. 1-PPV | Ran. 2-PPV | Ran. 3-PPV |
2 | 2,267.8 | 1,176.5 | 2,490.6 | 2,225.4 | 2,406.3 | 1,144.7 |
5 | 2,268.2 | 1,618.5 | 2,799.8 | 1,424.6 | 1,278.0 | 656.7 |
7 | 1,463.8 | 940.2 | 2,084.6 | 852.2 | 792.6 | 379.4 |
14 | 430.4 | 235.0 | 605.3 | 152.4 | 162.2 | 52.0 |
21 | 89.2 | 63.0 | 91.3 | 27.9 | 35.2 | 8.7 |
28 | 21.3 | 17.3 | 32.4 | 10.7 | 6.1 | |
35 | 10.9 | |||||
Day | Bev. 1-PPL | Bev. 2-PPL | Bev. 3-PPL | Ran. 1-PPL | Ran. 2-PPL | Ran. 3-PPL |
2 | 1,879.2 | 3,095.4 | 3,306.2 | 4,453.2 | 10,001.2 | 4,248.3 |
5 | 1,242.4 | 2,183.1 | 2,599.3 | 2,355.4 | 4,965.8 | 1,804.7 |
7 | 890.7 | 1,400.4 | 2,039.7 | 1,444.5 | 2,879.3 | 1,077.2 |
14 | 332.7 | 359.0 | 551.7 | 251.6 | 548.7 | 219.5 |
21 | 70.1 | 79.9 | 145.8 | 82.0 | 108.1 | 48.7 |
Bev., bevacizumab; PPL, pars plana lensectomy; PPV, pars plana vitrectomy; Ran., ranibizumab.